t is our great pleasure to report on the Knowledge Exchange Programme “Brain 2016”, an EAN-ESO Initiative, which was held in Mumbai, India, on January 16-17, 2016. This successful symposium, consisted of three main topics: stroke, epilepsy and migraine.
Get a glimpse of the key highlights, insights, and standout moments from EAN 2025 in Helsinki, all captured in our Congress Review eBook.
Latest Posts
-
-
EAN NewsEur J Neurol
European Journal of Neurology Publishes Open Access Articles – See the latest:
March 1, 2016The effect of pedunculopontine nucleus deep brain stimulation on postural sway and vestibular perception -
Munich Brain Course: Dissections, Clinical Correlates, Imaging
Institute of Anatomy, Ludwig Maximilian University Munich, Germany
March 16-19, 2016 The Munich Brain Course has been a yearly event since 2004. Each course has three main topics with additional presentations and hands-on… Continue Reading -
by Anna Sauerbier Outbreak of Zika Virus Disease – general information The Zika virus and potential neurological effects The European Medicines Agency (EMA) has released a revised guideline on medicines for the treatment of Alzheimer’s disease and other types… Continue Reading
-
Other News
The 8th European Board Examination in Neurology for young neurologists. Copenhagen May 27th 2016
March 1, 2016by Jan Kuks It should be mentioned, that part of this title is not correct. Yes, the 8th Examination for young neurologists will take place at the site of the EAN-congress in Copenhagen, and yes, it will be on May… Continue Reading
-
Are you already skilled at, or interested in learning how to write good Single Best Answer (SBA, multiple choice) questions?
The EAN Education committee is seeking expressions of interest from anyone in the European neurology community to support Continuing Medical… Continue Reading -
Executive Page
The scientific panels of the European Academy of Neurology: reorganisation of the think tank
February 1, 2016The purpose of EAN is to promote excellence in Neurology in Europe and among other topics the bylaws have detailed this ‘to increase the … standards of neurological services, to support neurological research and to be an organ speaking for neurology as the major medical specialty caring for patients with neurological disorders’. A very important structure of the Society to continuously fulfill this mission are the 31 scientific panels of EAN. These panels did exist already within the former Societies EFNS and ENS but they were organized differently. As they have received some reformation I would like to briefly outline their current function and why this reorganization was necessary. -
As in the previous year, Neuropenews asked EAN committee members, panel chairs, speakers etc. which session one should not miss at the upcoming congress in Copenhagen 2016. Please find their answers below!
-
Interviews
Interview with Dr. Saeed Bohlega, President PAUNS – Pan-Arab Union of Neurological Societies
February 1, 2016David Vodušek (DV): As president of PAUNS, can you please tell the Neuropenews readers of the organization’s history, its present activities and plans for the future? Saeed Bohlega (SB): PAUNS was conceived during the World Congress of Neurology (WCN) meeting in Barcelona, Spain in 1973 but it was only in 22nd May 1975 that PAUNS was officially founded. Under the leadership of the late Dr. Ahmed El Banhawy as first President, PAUNS came into existence in Cairo with the combination of various neuroscience societies in the Arab World, including specialists from countries lacking such societies. -
Disorders of the neuromuscular junction are relatively uncommon, but often misdiagnosed, especially at the onset of the disease. E-brain – the gold standard in interactive online learning for professionals in neurosciences contains comprehensive information about these disorders in the module… Continue Reading
-
Paper of the Month
Paper of the month: Efficacy and safety of andexanet to reverse factor Xa inhibitors activity.
February 1, 2016For February 2016 we have selected: Siegal DM, Curnutte JT, Connolly SJ, et al. Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med 2015;33:2413-2424. There is an increased use of direct factor Xa inhibitors (like apixaban, rivaroxaban, and edoxaban) to prevent stroke in patients with nonvalvular atrial fibrillation since these medications have several advantages compared to vitamin K antagonists. -
Forum
Neurological News from Denmark IV – the land of the 2nd EAN congress 2016: Research in multiple sclerosis in Denmark.
February 1, 2016Denmark has a 100-year history of research in multiple sclerosis (MS), but as everywhere, the number of published studies has grown almost exponentially during the last two decades. -
Education cornerEur J Neurol
European Journal of Neurology: CME article February 2016
February 1, 2016The new CME article February 2016: “Clinical dissection of childhood occipital epilepsy of Gastaut and prognostic implication” by A. Verrotti et. al. is online now! -
Education corner
Report from the Autumn Meeting of the UEMS Section of Neurology – European Board of Neurology, November 2015 by EAYNT/RRFS
February 1, 2016by Panagiotis Zis The Autumn Meeting of the UEMS Section of Neurology – European Board of Neurology took place on the 21st of November 2015 in Valencia, Spain during the Spanish National Neurology Conference. The delegates of most National Neurological… Continue Reading -
First of all, I want to thank EAN for unique opportunity to visit the Headache Clinic at the department of Neurology at the Evangelical Hospital in Unna, Germany.